h-header

news

News dal mondo

11

Ago

WHO continues work on quality of medicines

The World Health Organization designates new WHO-Listed Authorities, strengthening global access to quality-assured medical products

WHO has officially designated Health Canada, the Ministry of Health, Labour and Welfare/Pharmaceuticals and Medical Devices Agency (MHLW/PMDA) of Japan, and the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products.

With these latest designations, WHO expands the growing list of WLAs, now involving 39 agencies across the world, supporting faster and broader access to quality-assured medical products, particularly in low- and middle-income countries (LMICs)...[WHO]

02

Ott

Testo unico della legislazione farmaceutica in itinere: strategia per riportare produzione in Europa

"Difendere un settore che rappresenta per l'Italia una produzione da oltre 56 miliardi di euro...

02

Ott

AIFA Nuovo sistema informatico Workflow Officine Materie Prime

2 ottobre 2025 Comunicato “Nuovo sistema informatico Workflow Officine Materie Prime”  Dal...

26

Set

Medicines for Europe voices shock at ‘concerted efforts’ to water down CMA

Medicines for Europe has expressed shock at the “concerted efforts” of some Member States...

26

Set

Ministero Salute - Riportare in Italia la grande produzione farmaceutica di base

Dobbiamo riportare la produzione dei principi attivi in Italia, riportare in Italia o in Europa la grande...

slider-banner

h-footer